Skip to main content
. 2018 Apr 25;15(6):9757–9765. doi: 10.3892/ol.2018.8572

Figure 1.

Figure 1.

G9A expression is increased in HCC tissues. (A) Increased G9A expression level in HCC tissues (n=14) in comparison with adjacent noncancerous liver tissues analyzed using the reverse transcription-quantitative polymerase chain reaction analysis. (B) Increased G9A expression level in HCC tissues (n=22) in comparison with non-tumor tissues (n=21) in the GSE14520 training group. (C) Increased G9A expression level in HCC tissues (n=225) in comparison with non-tumor tissues (n=220) in the GSE14520 testing group. (D) Increased G9A expression level in HCC tissues (n=38) in comparison with normal tissues (n=19) in the GSE14323 dataset. (E) Increased G9A expression level in HCC tissues (n=35) in comparison with normal liver tissues (n=10) in the GSE6764 dataset. (F) Increased G9A expression level in HCC tissues (n=67) in comparison with normal tissues (n=10) in the GSE50579 dataset. ***P<0.001 as indicated. HCC, hepatocellular carcinoma; G9A, euchromatic histone-lysine N-methyltransferase.